← Browse by Condition
Medical Condition
metastatic renal cell carcinoma mrcc
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1, Phase 2
NCT07175480 Phase 2
Recruiting
PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk
Enrollment
30 pts
Location
China
Sponsor
Jinling Hospital, China
NCT07227415 Phase 1, Phase 2
Recruiting
A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Enrollment
224 pts
Location
United States, Austr...
Sponsor
Pfizer